Vaping and dabbing are the most prevalent routes of use among persons aged 18 to 24 years

Compared with those with all-cause hospital-based care and the general population, risk increased for those with cannabis use-based care

Review shows benefits for social responsiveness, disruptive behavior, and anxiety

Commercial administrative claims data show slight increase in annual prevalence from 2015 to 2020

Risk for death higher for individuals with hospital-based care for alcohol, stimulant, opioids versus cannabis use disorder

Schizophrenia-associated increase seen from prelegalization to legalization of nonmedical cannabis periods

Anterior insula, medial prefrontal cortex, and dorsolateral prefrontal cortex associated with history of heavy use

Findings seen for younger adults across cannabis use disorder severity levels